Litcius/Paper detail

3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies

Abdulsalam A. M. Alkhaldi, Mohammad M. Al‐Sanea, Alessio Nocentini, Wagdy M. Eldehna, Zainab M. Elsayed, Alessandro Bonardi, Mahmoud F. Abo-Ashour, Ashraf K. El‐Damasy, Mohammed S. Abdel‐Maksoud, Tarfah Al‐Warhi, Paola Gratteri, Hatem A. Abdel‐Aziz, Claudiu T. Supuran, Radwan El‐Haggar

2020European Journal of Medicinal Chemistry78 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryCarbonic anhydraseBenzimidazoleMoietyHydrazideStereochemistryDocking (animal)ConjugateSulfonamideCombinatorial chemistryEnzymeBiochemistryOrganic chemistryMedicineNursingMathematical analysisMathematicsEnzyme function and inhibitionSynthesis and Catalytic ReactionsCholinesterase and Neurodegenerative Diseases
3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies | Litcius